Leontiev V V, Uversky V N, Gudkov A T
Institute of Protein Research, Russian Academy of Sciences, Pushchino, Moscow Region.
Protein Eng. 1993 Jan;6(1):81-4. doi: 10.1093/protein/6.1.81.
Dihydrofolate reductase mutants with amino acid replacements in the active center (Thr35-->Asp mutant, Arg57-->His mutant and the mutant with triple replacement Thr35-->Asp, Asn37-->Ser, Arg57-->His) were obtained by site-directed mutagenesis. The stabilization effect of trimethoprim and NADP.H on the protein tertiary structure in vitro has been investigated. In the case of mutants with a 'weak' tertiary structure (Thr35-->Asp35 and the triple mutant) the separate addition of ligands does not affect their stability. The simultaneous addition of these ligands to Thr35-->Asp35 and the triple mutant leads to the large increase in their stability. A distinct correlation was found between the in vitro studied stability of the mutant proteins to the urea- or heat-induced denaturation and the level of proteolytic degradation of these mutants previously observed in vivo.
通过定点诱变获得了活性中心存在氨基酸替换的二氢叶酸还原酶突变体(苏氨酸35→天冬氨酸突变体、精氨酸57→组氨酸突变体以及苏氨酸35→天冬氨酸、天冬酰胺37→丝氨酸、精氨酸57→组氨酸三重替换的突变体)。研究了甲氧苄啶和NADP.H对体外蛋白质三级结构的稳定作用。对于具有“弱”三级结构的突变体(苏氨酸35→天冬氨酸35和三重突变体),单独添加配体不会影响其稳定性。将这些配体同时添加到苏氨酸35→天冬氨酸35和三重突变体中会导致其稳定性大幅增加。在体外研究的突变体蛋白质对尿素或热诱导变性的稳定性与先前在体内观察到的这些突变体的蛋白水解降解水平之间发现了明显的相关性。